Publication | Open Access
Antigenic response to <scp>CT</scp>‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition
23
Citations
23
References
2018
Year
These results strongly support a similar antigenic profile for infliximab originator and CT-P13, and point toward a safe switching between the two drugs in anti-drug antibody negative patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1